Icg: Clinical Trials

6 trials of Icg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 2 unknown, 2 withdrawn. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Recruiting 2, Unknown 2, Withdrawn 2

Follow Icg: new trials by email Literature Review of Icg trials Research Report on Icg

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Intraoperative Indocyanine Green Fluorescence Imaging With Standard Clinical Assessment for Flap Perfusion in Head and Neck Reconstruction (VISION Trial)
Indocyanine Green, Standard clinical perfusion assessment - Head and Neck Cancer (H&N), Free Tissue Flaps
Phase 4RecruitingRegion Skane2442026-09-282026-09-29
Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery
Indocyanine Green - Giant Cell Tumor of Bone
Phase 4RecruitingShanghai Jiao Tong University Affiliated Sixth People's Hospital402026-01-022026-01-05
Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography
Indocyanine green - Neuroma, Neuroma Amputation
Phase 4WithdrawnNorthwestern University2024-12-282025-01-01
Indocyanine Green to Visualize Critical View of Safety During Laparoscopic Cholecystectomy for Acute Cholecystitis
Indocyanine Green - Acute Cholecystitis, Acute; Cholecystitis, Choledocholithiasis
Phase 4UnknownHamad Medical Corporation802021-01-012020-12-16
Intraoperative ICG for Systemic Sclerosis
Order of two elements of surgical procedure, Indocyanine Green - Systemic Sclerosis
Phase 4WithdrawnDuke University2017-06-012020-06-30
Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy
Indocyanine Green - Hypocalcemia, Total Thyroidectomy
Phase 4UnknownHospital Son Espases402016-11-012019-07-09

Conditions studied

Cholecystitis (1)  ·  Cholecystitis, Acute (1)  ·  Choledocholithiasis (1)  ·  Giant Cell Tumor of Bone (1)  ·  Head and Neck Neoplasms (1)  ·  Hypocalcemia (1)  ·  Neuroma (1)  ·  Scleroderma, Systemic (1)

Sponsors

Duke University (1)  ·  Hamad Medical Corporation (1)  ·  Hospital Son Espases (1)  ·  Northwestern University (1)  ·  Region Skane (1)  ·  Shanghai Jiao Tong University Affiliated Sixth People's Hospital (1)

Countries

China (1)  ·  Qatar (1)  ·  Spain (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Gregory A Dumanian, MD (1)  ·  Pooya Rajabaleyan, MD, PhD (1)  ·  Suhail Mithani, MD (1)  ·  Zia Aftab, MBBS, FACS (1)

Results publications

PMID 17013643, PMID 21613624, PMID 30327136, PMID 31188797, PMID 32224746, PMID 33094400, PMID 33214476, PMID 33754215, PMID 37121582, PMID 37121591, PMID 37178368

NIH funding

2025 (1)